Imperva (IMPV) Tops Q2 EPS by 7c

Imperva (NASDAQ: IMPV) reported Q2 EPS of ($0.26), $0.07 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $84.8 million versus the consensus estimate of $87.16 million.

For earnings history and earnings-related data on Imperva (IMPV) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• SYNNEX Corp. (SNX) Tops Q2 EPS by 74c, Beats on Revenue; Offers Q3 Guidance
• H.B. Fuller (FUL) Tops Q2 EPS by 3c; Offers Outlook